A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer
A Novel Decision Aid for Early Stage Breast Cancer Patients Choosing Between Lumpectomy and Mastectomy: a Pilot Study
University of Colorado, Denver
60 participants
Jul 21, 2025
INTERVENTIONAL
Conditions
Summary
This is a study to assess the feasibility and acceptability of a novel decision aid (DA) in a newly diagnosed, early-stage breast cancer population. Insights gained from patient feedback and the implementation process will be used to improve the information delivered in the decision aid itself and to plan for a larger scale trial to compare the decision aid to standard of care.
Eligibility
Inclusion Criteria4
- Adult women age 18-100
- English speaking
- Clinical stage 0-III breast cancer
- Eligible for both lumpectomy and mastectomy
Exclusion Criteria3
- Prior surgical consultation regarding treatment options for breast cancer
- Previous history of breast cancer
- Requires neoadjuvant chemotherapy prior to surgical intervention
Interventions
Tools designed to foster shared decision-making by contextualizing the risks and benefits of treatment options around the patient's personal values, thereby allowing them to weigh personal preferences when making treatment decisions. The study team has developed a prototype DA incorporating longitudinal institutional QoL data among patients who have undergone breast cancer surgery .
Electronic copy of an alternative educational pamphlet discussing surgical options for breast cancer.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06813053